{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:30:16Z","timestamp":1786120216009,"version":"build-2736575974"},"reference-count":35,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1097\/mou.0b013e32834d5469","type":"journal-article","created":{"date-parts":[[2011,11,10]],"date-time":"2011-11-10T05:06:43Z","timestamp":1320901603000},"page":"16-21","source":"Crossref","is-referenced-by-count":7,"title":["Revival of thermotherapy for benign prostatic hyperplasia"],"prefix":"10.1097","volume":"22","author":[{"given":"Bob","family":"Djavan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir","family":"Kazzazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yakup","family":"Bostanci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-4-20210206","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/(SICI)1097-0045(19970501)31:2<131::AID-PROS9>3.0.CO;2-Q","article-title":"Intrinsic and extrinsic factors controlling benign prostatic growth.","volume":"31","author":"Lee","year":"1997","journal-title":"Prostate"},{"key":"R2-4-20210206","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.ucl.2009.07.004","article-title":"Established medical therapy for benign prostatic hyperplasia.","volume":"36","author":"Auffenberg","year":"2009","journal-title":"Urol Clin North Am"},{"key":"R3-4-20210206","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.pop.2010.04.004","article-title":"Benign prostatic hyperplasia: current clinical practice.","volume":"37","author":"Djavan","year":"2010","journal-title":"Prim Care"},{"key":"R4-4-20210206","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1056\/NEJMoa030656","article-title":"The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia.","volume":"349","author":"McConnell","year":"2003","journal-title":"N Engl J Med"},{"key":"R5-4-20210206","first-page":"269","article-title":"Minimally invasive surgery in the management of benign prostatic hyperplasia.","volume":"61","author":"Berardinelli","year":"2009","journal-title":"Minerva Urol Nefrol"},{"key":"R6-4-20210206","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1046\/j.1464-410X.1996.17213.x","article-title":"The heat is on - but how A comparison of TUMT devices.","volume":"78","author":"Bolmsjo","year":"1996","journal-title":"Br J Urol"},{"key":"R7-4-20210206","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1097\/01.ju.0000129967.30558.ca","article-title":"Transurethral microwave thermotherapy for benign prostate hyperplasia: separating truth from marketing hype.","volume":"172","author":"Walmsley","year":"2004","journal-title":"J Urol"},{"key":"R8-4-20210206","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0090-4295(99)00029-1","article-title":"Temporary intraurethral prostatic bridge-catheter compared with neoadjuvant and adjuvant alpha-blockade to improve early results of high-energy transurethral microwave thermotherapy.","volume":"54","author":"Djavan","year":"1999","journal-title":"Urology"},{"key":"R10-4-20210206","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1097\/01.ju.0000169266.20149.29","article-title":"Seeking evidence that cell kill guided thermotherapy gives results not inferior to those of transurethral prostate resection: results of a pooled analysis of 3 studies of feedback transurethral microwave thermotherapy.","volume":"174","author":"Gravas","year":"2005","journal-title":"J Urol"},{"key":"R11-4-20210206","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1089\/089277902753483745","article-title":"Office-based transurethral microwave thermotherapy using the TherMatrx TMx-2000.","volume":"16","author":"Albala","year":"2002","journal-title":"J Endourol"},{"key":"R12-4-20210206","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/j.1442-2042.2007.01692.x","article-title":"Long-term results of three different minimally invasive therapies for lower urinary tract symptoms due to benign prostatic hyperplasia: comparison at a single institute.","volume":"14","author":"Ohigashi","year":"2007","journal-title":"Int J Urol"},{"key":"R13-4-20210206","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1016\/S0022-5347(05)65187-7","article-title":"Baseline prostatic specific antigen does not predict the outcome of high energy transurethral microwave thermotherapy.","volume":"167","author":"Laguna","year":"2002","journal-title":"J Urol"},{"key":"R14-4-20210206","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/S0090-4295(00)00854-2","article-title":"Targeted transurethral microwave thermotherapy versus alpha-blockade in benign prostatic hyperplasia: outcomes at 18 months.","volume":"57","author":"Djavan","year":"2001","journal-title":"Urology"},{"key":"R15-4-20210206","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1016\/S0090-4295(03)00337-6","article-title":"Cooled thermotherapy for the treatment of benign prostatic hyperplasia: durability of results obtained with the targis system.","volume":"61","author":"Miller","year":"2003","journal-title":"Urology"},{"key":"R16-4-20210206","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/S0302-2838(02)00547-X","article-title":"Transurethral microwave thermotherapy (TUMT) with the Targis System: a single-centre study on 78 patients with acute urinary retention and poor general health.","volume":"43","author":"Berger","year":"2003","journal-title":"Eur Urol"},{"key":"R17-4-20210206","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0022-5347(01)62084-6","article-title":"Prospective randomized comparison of high energy transurethral microwave thermotherapy versus alpha-blocker treatment of patients with benign prostatic hyperplasia.","volume":"161","author":"Djavan","year":"1999","journal-title":"J Urol"},{"key":"R18-4-20210206","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.urology.2007.01.070","article-title":"Durability of 30-min high-energy transurethral microwave therapy for treatment of benign prostatic hyperplasia: a study of 213 patients with and without urinary retention.","volume":"69","author":"Gravas","year":"2007","journal-title":"Urology"},{"key":"R19-4-20210206","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1016\/j.juro.2010.12.054","article-title":"Results of a 5-year multicenter trial of a new generation cooled high energy transurethral microwave thermal therapy catheter for benign prostatic hyperplasia.","volume":"185","author":"Mynderse","year":"2011","journal-title":"J Urol"},{"key":"R21-4-20210206","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1016\/S0022-5347(05)66343-4","article-title":"Long-term follow up of randomized transurethral microwave thermotherapy versus transurethral prostatic resection study.","volume":"165","author":"Floratos","year":"2001","journal-title":"J Urol"},{"key":"R24-4-20210206","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1080\/003655902753679391","article-title":"Long-term clinical outcome of transurethral microwave thermotherapy (TUMT) 1991-1999 at Karolinska Hospital, Sweden.","volume":"36","author":"Ekstrand","year":"2002","journal-title":"Scand J Urol Nephrol"},{"key":"R25-4-20210206","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1046\/j.1464-410X.1998.00542.x","article-title":"Transurethral resection of the prostate vs high-energy thermotherapy of the prostate in patients with benign prostatic hyperplasia: long-term results.","volume":"81","author":"DAncona","year":"1998","journal-title":"Br J Urol"},{"key":"R26-4-20210206","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1016\/S0022-5347(05)65013-6","article-title":"Transurethral microwave therapy in 200 patients with a minimum follow up of 2 years: urodynamic and clinical results.","volume":"167","author":"Thalmann","year":"2002","journal-title":"J Urol"},{"key":"R27-4-20210206","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1089\/end.2005.19.730","article-title":"Transurethral microwave thermotherapy: clinical results after 11 years of use.","volume":"19","author":"Vesely","year":"2005","journal-title":"J Endourol"},{"key":"R28-4-20210206","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S0090-4295(99)00143-0","article-title":"High-energy transurethral microwave thermotherapy in patients with acute urinary retention due to benign prostatic hyperplasia.","volume":"54","author":"Djavan","year":"1999","journal-title":"Urology"},{"key":"R29-4-20210206","first-page":"83","article-title":"High energy microwave thermotherapy for symptomatic benign prostatic enlargment: predictive parameters of long term outcome.","volume":"83","author":"Lucarelli","year":"2011","journal-title":"Arch Ital Urol Androl"},{"key":"R30-4-20210206","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1089\/end.2007.0039","article-title":"High-energy transurethral thermotherapy with CoreTherm approaches transurethral prostate resection in outcome efficacy: a meta-analysis.","volume":"22","author":"Kaye","year":"2008","journal-title":"J Endourol"},{"key":"R31-4-20210206","first-page":"245","article-title":"Transurethral microwave thermotherapy: the gold standard for minimally invasive therapies for patients with benign prostatic hyperplasia J E","volume":"17","author":"De la Rosette","year":"2003","journal-title":"ndourol"},{"key":"R32-4-20210206","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1046\/j.1464-410X.2002.03031.x","article-title":"Transurethral interstitial laser coagulation of the prostate and transurethral microwave thermotherapy vs transurethral resection or incision of the prostate: results of a randomized, controlled study in patients with symptomatic benign prostatic hyperplasia.","volume":"90","author":"Norby","year":"2002","journal-title":"BJU Int"},{"key":"R33-4-20210206","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1016\/S0022-5347(05)67142-X","article-title":"Impact of interventional therapy for benign prostatic hyperplasia on quality of life and sexual function: a prospective study.","volume":"164","author":"Arai","year":"2000","journal-title":"J Urol"},{"key":"R34-4-20210206","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1046\/j.1464-410X.1997.02667.x","article-title":"Transurethral microwave thermotherapy (Prostatron version 2.5) compared with transurethral resection of the prostate for the treatment of benign prostatic hyperplasia: a randomized, controlled, parallel study.","volume":"79","author":"Ahmed","year":"1997","journal-title":"Br J Urol"},{"key":"R35-4-20210206","first-page":"19","article-title":"Microwave thermotherapy for benign prostatic hyperplasia with the Dornier Urowave: results of a randomized, double-blind, multicenter, sham-controlled trial.","volume":"51","author":"Roehrborn","year":"1998","journal-title":"Urology"},{"key":"R36-4-20210206","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1089\/end.1994.8.217","article-title":"Ejaculatory dysfunction after transurethral microwave thermotherapy for treatment of benign prostatic hyperplasia.","volume":"8","author":"Rodrigues Netto","year":"1994","journal-title":"J Endourol"},{"key":"R37-4-20210206","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/S0090-4295(98)00502-0","article-title":"Results of high-energy transurethral microwave thermotherapy in patients categorized according to the American Society of Anesthesiologists operative risk classification.","volume":"53","author":"DAncona","year":"1999","journal-title":"Urology"},{"key":"R38-4-20210206","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/sj.pcan.4500293","article-title":"High energy transurethral thermotherapy in the treatment of benign prostatic hyperplasia: criteria to predict treatment outcome.","volume":"2","author":"DAncona","year":"1999","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"R39-4-20210206","first-page":"5249","article-title":"Durability and retreatment rates of minimal invasive treatments of benign prostatic hyperplasia: a cross-analysis of the literature.","volume":"17","author":"Djavan","year":"2010","journal-title":"Can J Urol"}],"container-title":["Current Opinion in Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MOU.0b013e32834d5469","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T20:27:12Z","timestamp":1786048032000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00042307-201201000-00004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/mou.0b013e32834d5469","relation":{},"ISSN":["0963-0643"],"issn-type":[{"value":"0963-0643","type":"print"}],"subject":[],"published":{"date-parts":[[2012,1]]}}}